Investigating a stock’s 52-week price history, covering the range of low and high prices, can provide significant information about its present state and future potential. Coherus Biosciences Inc’s current trading price is -61.35% away from its 52-week high, while its distance from the 52-week low is 116.57%. The stock’s price range during this period has varied between $0.66 and $3.70. The company, active in the Healthcare sector, saw a trading volume of around 2.99 million for the day, considerably lower average daily volume of 5.2 million observed over the last three months.
Coherus Biosciences Inc’s stock has seen a rocky market performance. The company’s stock achieved a 1-year high of $3.70 on 01/02/24, and the lowest price during that time was $0.66, recorded on 11/05/24.
How Financial Performance Impacts Market Capitalization
Coherus Biosciences Inc (CHRS) has experienced a quarterly rise of 43.00% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 169.20M and boasts a workforce of 306 employees.
The Role of Moving Averages and Trading Volume in Technical Analysis
Based on Barchart.com data, the company’s moving average over the 100-day period was 1.1638, with a change in price of unch. Similarly, Coherus Biosciences Inc recorded 4,080,693 in trading volume during the last 100 days, posting a change of unch.
CHRS Stock Stochastic Average
As of today, the raw stochastic average of Coherus Biosciences Inc over the past 50 days is 43.49%. This is a increase compared to the raw stochastic average of the last 20 days, which was recorded at 23.66%. Additionally, the Stochastic %K and %D values for the company were 30.27% and 38.00%, respectively, over the past 20 days.
CHRS Stock Price Performance Analysis
The stock price performance for the year has been a mixed bag, indicating either a pessimistic or optimistic outlook depending on how you look at it. This year’s metric has recorded a Price decrease of -57.06%. However, over the past six months, we’ve seen a stronger performance of -9.49%. The price of CHRS fallen by 30.00% over the last 30 days. And in the last five days, it has fallen by -15.88%.
